Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management

References

• Delsol G, Lamant L, Mariamé B, et al. A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood. 1997;89(5):1483–1490.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues – IARC. Vol 2. 4th ed. Lyon, France: IARC; 2017.
   Google Scholar
• Castillo JJ, Chavez JC, Hernandez-Ilizaliturri FJ, Montes-Moreno S. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options. Expert Rev Hematol. 2015;8(3):343–354.
   PubMed Web of Science ®Google Scholar
• Park JP, Curran MJ, Levy NB, et al. Diffuse large cell, B-cell type lymphoma with a novel translocation (2;22)(p23;q11.2). Cancer Genet Cytogenet. 1997;96(2):118–122.
   PubMedGoogle Scholar
• De Paepe P, Baens M, Van Krieken H, et al. ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood. 2003;102(7):2638–2641.
   PubMed Web of Science ®Google Scholar
• Gascoyne RD, Lamant L, Martin-Subero JI, et al. ALK-positive diffuse large B-cell lymphoma is associated with clathrin-ALK rearrangements: report of 6 cases. Blood. 2003;102(7):2568–2573.
   PubMed Web of Science ®Google Scholar
• Onciu M, Behm FG, Downing JR, et al. ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood. 2003;102(7):2642–2644.
   PubMed Web of Science ®Google Scholar
• Adam P, Katzenberger T, Seeberger H, et al. A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation. Am J Surg Pathol. 2003;27(11):1473–1476.
   Web of Science ®Google Scholar
• Chikatsu N, Kojima H, Suzukawa K, et al. ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod Pathol. 2003;16(8):828–832.
   PubMed Web of Science ®Google Scholar
• Colomo L, Loong F, Rives S, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28(6):736–747.
   PubMed Web of Science ®Google Scholar
• McManus DT, Catherwood MA, Carey PD, et al. ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement. Hum Pathol. 2004;35(10):1285–1288.
   PubMed Web of Science ®Google Scholar
• Gesk S, Gascoyne RD, Schnitzer B, et al. ALK-positive diffuse large B-cell lymphoma with ALK-Clathrin fusion belongs to the spectrum of pediatric lymphomas. Leukemia. 2005;19(10):1839–1840.
   PubMed Web of Science ®Google Scholar
• Bubała H, Małdyk J, Włodarska I, et al. ALK-positive diffuse large B-cell lymphoma. Pediatr Blood Cancer. 2006;46(5):649–653.
   PubMed Web of Science ®Google Scholar
• Rudzki Z, Rucińska M, Jurczak W, et al. ALK-positive diffuse large B-cell lymphoma: two more cases and a brief literature review. Pol J Pathol. 2005;56(1):37–45.
   PubMedGoogle Scholar
• Isimbaldi G, Bandiera L, d’Amore ESG, et al. ALK-positive plasmablastic B-cell lymphoma with the clathrin-ALK gene rearrangement. Pediatr Blood Cancer. 2006;46(3):390–391.
   PubMed Web of Science ®Google Scholar
• Reichard KK, McKenna RW, Kroft SH. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. Mod Pathol. 2007;20(3):310–319.
   PubMed Web of Science ®Google Scholar
• Stachurski D, Miron PM, Al-Homsi S, et al. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma with a complex karyotype and cryptic 3' ALK gene insertion to chromosome 4 q22-24. Hum Pathol. 2007;38(6):940–945.
   PubMed Web of Science ®Google Scholar
• Lee HW, Kim K, Kim W, et al. ALK-positive diffuse large B-cell lymphoma: report of three cases. Hematol Oncol. 2008;26(2):108–113.
   PubMed Web of Science ®Google Scholar
• Momose S, Tamaru J, Ichi Kishi H, et al. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion. Hum Pathol. 2009;40(1):75–82.
   PubMed Web of Science ®Google Scholar
• Zhang D, Denley RC, Filippa DA, et al. ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23). Appl Immunohistochem Mol Morphol. 2009;17(2):172–177.
   PubMedGoogle Scholar
• Beltran B, Castillo J, Salas R, et al. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature. J Hematol Oncol. 2009;2:11.
   PubMed Web of Science ®Google Scholar
• Laurent C, Do C, Gascoyne RD, et al. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis. J Clin Oncol. 2009;27(25):4211–4216.
   PubMed Web of Science ®Google Scholar
• Van Roosbroeck K, Cools J, Dierickx D, et al. ALK-positive large B-cell lymphomas with cryptic SEC31A-ALK and NPM1-ALK fusions. Haematologica. 2010;95(3):509–513.
   PubMed Web of Science ®Google Scholar
• Li K, Tipps AMP, Wang H-Y. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting as an isolated nasopharyngeal mass: a case report and review of literature. Int J Clin Exp Pathol. 2010;4(2):190–196.
   PubMed Web of Science ®Google Scholar
• Shi M, Minehart Miron P, Hutchinson L, et al. Anaplastic lymphoma kinase-positive large B-cell lymphoma with complex karyotype and novel ALK gene rearrangements. Hum Pathol. 2011;42(10):1562–1567.
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Soda M, Togashi Y, et al. Identification of a novel fusion, SQSTM1-ALK, in ALK-positive large B-cell lymphoma. Haematologica. 2011;96(3):464–467.
   PubMed Web of Science ®Google Scholar
• Bedwell C, Rowe D, Moulton D, et al. Cytogenetically complex SEC31A-ALK fusions are recurrent in ALK-positive large B-cell lymphomas. Haematologica. 2011;96(2):343–346.
   PubMed Web of Science ®Google Scholar
• Yin WH, Guo N, Tian XY, et al. Pediatric anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report and review of the literature. Pediatr Dev Pathol. 2012;15(4):318–323.
   PubMed Web of Science ®Google Scholar
• Valera A, Colomo L, Martínez A, et al. ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. Mod Pathol. 2013;26(10):1329–1337.
   PubMed Web of Science ®Google Scholar
• Wass M, Behlendorf T, Schädlich B, et al. Crizotinib in refractory ALK-positive diffuse large B-cell lymphoma: a case report with a short-term response. Eur J Haematol. 2014;92(3):268–270.
   PubMed Web of Science ®Google Scholar
• Ishida M, Yoshida K, Kagotani A, et al. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report with emphasis on the cytological features of the pleural effusion. Int J Clin Exp Pathol. 2013;6(11):2631–2635.
   PubMed Web of Science ®Google Scholar
• d’Amore ESG, Visco C, Menin A, et al. STAT3 pathway is activated in ALK-positive large b-cell lymphoma carrying SQSTM1-ALK rearrangement and provides a possible therapeutic target. Am J Surg Pathol. 2013;37(5):780–786.
   PubMed Web of Science ®Google Scholar
• Llamas-Gutiérrez FJ, Deffis Court M, Ponciano Castellanos A, et al. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a case report with particular immunophenotypic features. Hum Pathol. 2013;44(7):1429–1433.
   PubMed Web of Science ®Google Scholar
• Sellami-Dhouib R, Nasfi A, Mejri NT, et al. Ovarian ALK + diffuse large B-cell lymphoma: a case report and a review of the literature. Int J Gynecol Pathol. 2013;32(5):471–475.
   PubMed Web of Science ®Google Scholar
• Lin O, Koreishi A, Brandt SM, et al. ALK + large B-cell lymphoma: a rare variant of aggressive large B-cell lymphoma mimicking carcinoma on cytology specimens. Diagn Cytopathol. 2013;41(5):404–407.
   PubMed Web of Science ®Google Scholar
• Chen YP, Hung LY, Shan YS et al. ALK-positive large B-cell lymphoma presenting with jejunal intussusception. Eur J Haematol. 2013;90(3):261–261.
   PubMed Web of Science ®Google Scholar
• Nakatsuka SI, Oku K, Nagano T, et al. A case of anaplastic lymphoma kinase-positive large B-cell lymphoma: aspiration cytology findings. Diagn Cytopathol. 2014;42(1):69–72.
   PubMed Web of Science ®Google Scholar
• Chapman-Fredricks J, Blieden C, Sandoval JD, et al. Acute spontaneous tumor lysis syndrome as the initial presentation of ALK-positive diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol. 2014;22(4):317–321.
   PubMedGoogle Scholar
• Sachdev R, Goel S, Gupta S, et al. Anaplastic lymphoma kinase (ALK) positive diffuse large B cell lymphoma in a 20 year old: a rare entity. Indian J Pathol Microbiol. 2014;57(1):157–158.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Fujimoto M, Nishikori M, et al. Plasmacytic ALK-positive large B-cell lymphoma: a potential mimic of extramedullary plasmacytoma. Pathol Int. 2014;64(6):292–294.
   PubMed Web of Science ®Google Scholar
• Xing X, Lin D, Ran W, et al. ALK-positive diffuse large B-cell lymphoma of the duodenum: a case report and review of the literature. Exp Ther Med. 2014;8(2):409–412.
   PubMed Web of Science ®Google Scholar
• Li J, Ouyang J, Zhou R, et al. Promising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literature. Int J Clin Exp Med. 2015;8(5):6977–6985.
   PubMed Web of Science ®Google Scholar
• Chen J, Feng X, Dong M. Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma presenting in nasal cavity: a case report and review of literature. Int J Clin Exp Pathol. 2015;8(2):2123–2130.
   PubMed Web of Science ®Google Scholar
• Yu H, Huang J, Sun J, et al. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a potential diagnostic pitfall. Indian J Pathol Microbiol. 2015;58(2):241–245.
   PubMed Web of Science ®Google Scholar
• Lin SY, Chuang SS, Jhuang JY, et al. ALK positive large B-cell lymphoma with a massive neutrophilic infiltrate: report of a case mimicking epithelioid inflammatory myofibroblastic tumour. J Clin Pathol. 2015;68(6):496–498.
   PubMed Web of Science ®Google Scholar
• Zanelli M, Valli R, Capodanno I, et al. Anaplastic lymphoma kinase-positive large B-cell lymphoma: description of a case with an unexpected clinical outcome. Int J Surg Pathol. 2015;23(1):78–83.
   PubMed Web of Science ®Google Scholar
• Mehra V, Pomplum S, Ireland R, et al. ALK-positive large B-cell lymphoma with strong CD30 expression; a diagnostic pitfall and resistance to brentuximab and crizotinib. Histopathology. 2016;69(5):880–882.
   PubMed Web of Science ®Google Scholar
• Jain D, Mallick SR, Singh V, et al. Napsin a expression in anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a diagnostic pitfall. Appl Immunohistochem Mol Morphol. 2016;24(5):e34–e40.
   PubMedGoogle Scholar
• Quesada AE, Huh YO, Wang W, et al. Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma in a patient treated with azathioprine for ulcerative colitis. Pathology. 2016;48(5):513–515.
   PubMed Web of Science ®Google Scholar
• Sakr H, Cruise M, Chahal P, et al. Anaplastic lymphoma kinase positive large B-cell lymphoma: literature review and report of an endoscopic fine needle aspiration case with tigroid backgrounds mimicking seminoma. Diagn Cytopathol. 2017;45(2):148–155.
   PubMed Web of Science ®Google Scholar
• Xiong H, Liu SY, Yang YX, et al. An unusual case of anaplastic lymphoma kinase-positive large B-cell lymphoma in an elderly patient: a case report and discussion. Exp Ther Med. 2016;11(5):1799–1802.
   PubMed Web of Science ®Google Scholar
• Duarte AF, Squire JA, Chahud F, et al. Lacrimal gland anaplastic kinase-positive large B-cell lymphoma (LBCL-ALK+) with an atypical clinical presentation. Clin Exp Ophthalmol. 2016;44(6):520–522.
   PubMed Web of Science ®Google Scholar
• Pan Z, Hu S, Li M, et al. ALK-positive large b-cell lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature. Am J Surg Pathol. 2017;41(1):25–38.
   PubMed Web of Science ®Google Scholar
• Jiang XN, Yu BH, Wang WG, et al. Anaplastic lymphoma kinase-positive large B-cell lymphoma: clinico-pathological study of 17 cases with review of literature. PLOS One. 2017;12(6):e0178416.
   PubMed Web of Science ®Google Scholar
• Salat H, Din NU, Moatter T, et al. Anaplastic lymphoma kinase protein positive diffuse large B cell lymphoma; A developing world experience. Pathol Res Pract. 2017;213(6):649–653.
   PubMed Web of Science ®Google Scholar
• Shi Y, Li X, Song Y, et al. Relapsed anaplastic lymphoma kinase-positive large B-cell lymphoma expressed cluster of differentiation 4 and cytokeratin: an initially misdiagnosed case corrected by immunoglobulin κ locus gene rearrangement detection. Oncol Lett. 2017;14(1):787–791.
   PubMed Web of Science ®Google Scholar
• Corean J, Li KD. A rare case of ALK-positive large B-cell lymphoma with CD33 expression. Case Rep Hematol. 2018;2018:5320590.
   PubMed Web of Science ®Google Scholar
• Ise M, Kageyama H, Araki A, et al. Identification of a novel GORASP2-ALK fusion in an ALK-positive large B-cell lymphoma. Leuk Lymphoma. 2019;60(2):493–497.
   PubMed Web of Science ®Google Scholar
• Vanidassane I, Gogia A, Mallick S. Adult ALK-positive diffuse large B-cell lymphoma: a limited institutional experience. Indian J Cancer. 2019;56(4):373–374.
   PubMed Web of Science ®Google Scholar
• Kempf W, Torricelli R, Zettl A, et al. Primary cutaneous anaplastic lymphoma kinase-positive large B-cell lymphoma. Am J Dermatopathol. 2019;41(8):602–605.
   PubMed Web of Science ®Google Scholar
• Bhaskar S, Abro B, Fraum TJ, et al. Lenalidomide demonstrates clinical activity in anaplastic lymphoma kinase-positive large B-cell lymphoma. BMJ Case Rep. 2020;13(8):e235578.
   PubMedGoogle Scholar
• Khanlari M, Jeffrey Medeiros L. ALK + large B-cell lymphoma with aberrant expression of CD3. Blood. 2020;136(26):3086.
   PubMed Web of Science ®Google Scholar
• Sandoval-Sus JD, Brahim A, Khan A, et al. Complete response of primary refractory ALK-positive large B-cell lymphoma treated with single-agent nivolumab. Clin Lymphoma Myeloma Leuk. 2020;20(3):e113–e117.
   PubMed Web of Science ®Google Scholar
• Subramaniam A, Gnanasekaran D, Suruliraj S, et al. Anaplastic Lymphoma Kinase positive large B cell lymphoma of ileocaecal mesentery: a case report. Indian J Pathol Microbiol. 2020;63(4):615–617.
   PubMed Web of Science ®Google Scholar
• Hallberg B, Palmer RH. The role of the ALK receptor in cancer biology. Ann Oncol. 2016;27:iii4–iii15.
   PubMedGoogle Scholar
• Lee SE, Kang SY, Takeuchi K, et al. Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. Hematol Oncol. 2014;32(4):221–224.
   PubMed Web of Science ®Google Scholar
• Sakamoto K, Nakasone H, Togashi Y, et al. ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern. Int J Hematol. 2016;103(4):399–408.
   PubMed Web of Science ®Google Scholar
• Cerchietti L, Damm-Welk C, Vater I, et al. Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas. PLOS One. 2011;6(4):e18436.
   Google Scholar
• Li S. Anaplastic lymphoma kinase-positive large B-cell lymphoma: a distinct clinicopathological entity. Int J Clin Exp Pathol. 2009;2(6):508–518.
   PubMed Web of Science ®Google Scholar
• Sukswai N, Lyapichev K, Khoury JD, et al. Diffuse large B-cell lymphoma variants: an update. Pathology. 2020;52(1):53–67.
   PubMed Web of Science ®Google Scholar
• Grimm KE, O'Malley DP. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues. Ann Diagn Pathol. 2019;38:6–10.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015;125(15):2323–2330.
   PubMed Web of Science ®Google Scholar
• Lasota J, Chłopek M, Lamoureux J, et al. Colonic adenocarcinomas harboring NTRK fusion genes: a clinicopathologic and molecular genetic study of 16 cases and review of the literature. Am J Surg Pathol. 2020;44(2):162–173.
   PubMed Web of Science ®Google Scholar
• Qunaj L, Castillo JJ, Olszewski AJ. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base. Leuk Lymphoma. 2018;59(6):1375–1383.
   PubMed Web of Science ®Google Scholar
• Castillo JJ, Guerrero-Garcia T, Baldini F, et al. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. Br J Haematol. 2019;184(4):679–682.
   PubMed Web of Science ®Google Scholar
• Saba NS, Dang D, Saba J, et al. Bortezomib in plasmablastic lymphoma: a case report and review of the literature. Onkologie. 2013;36(5):287–291.
   PubMedGoogle Scholar
• Marrero WD, Cruz-Chacón A, Castillo C, et al. Successful use of bortezomib-lenalidomide combination as treatment for a patient with plasmablastic lymphoma. Clin Lymphoma Myeloma Leuk. 2018;18(7):e275–e277.
   PubMed Web of Science ®Google Scholar
• Bibas M, Grisetti S, Alba L, et al. Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. J Clin Oncol. 2010;28(34):e704–e708.
   PubMed Web of Science ®Google Scholar